Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer
<p dir="ltr">Immune response modulation has allowed for breakthrough progress in the treatment of many solid as well as haematological malignancies. To date, immune check-point inhibitors have been approved as first or second line therapy options in a broadening range of metastatic c...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , |
| Published: |
2021
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|